MAPK Signaling
MAPK Signaling(MAPK信号通路)
MAPK Signaling 相关产品(575)
| 货号 | 产品名称 | CAS号 | 纯度 | 结构 |
|---|---|---|---|---|
| GC11076 | XMD8-92 | 1234480-50-2 | >98.00% | |
XMD8-92是一种BMK1激酶抑制剂，IC 50 为1.5μM，解离常数（Kd）为80nM。 | ||||
| GC11157 | LL-Z 1640-4 | 66018-41-5 | - | |
A negative control for MAPK signaling | ||||
| GC11180 | CMPD-1 | 41179-33-3 | >99.00% | |
A substrate-selective p38α MAPK inhibitor | ||||
| GC11277 | MEK inhibitor | 334951-92-7 | >98.50% | |
MEK 抑制剂是一种有效的 MEK 抑制剂，具有抗肿瘤效力。 | ||||
| GC11307 | ML-264 | 1550008-55-3 | >99.50% | |
A selective KLF5 inhibitor | ||||
| GC11362 | K 252a | 99533-80-9 | >98.00% | |
A non-selective PKC inhibitor | ||||
| GC11422 | Ulixertinib (hydrochloride) | 1956366-10-1 | >99.50% | |
An ERK1/2 inhibitor | ||||
| GC11497 | BIRB 796 (Doramapimod) | 285983-48-4 | >99.50% | |
A potent inhibitor of p38 MAPK | ||||
| GC11542 | SU 3327 | 40045-50-9 | >98.50% | |
A JNK1 inhibitor with antidiabetic and antibiotic activity | ||||
| GC11559 | Anisomycin | 22862-76-6 | >98.50% / >98.00% | |
Anisomycin是一种从灰链霉菌中分离出来的抗生素，也是一种JNK激活剂。 | ||||
| GC11605 | C-1 | 84468-24-6 | >99.50% | |
C-1 是一种有效的蛋白激酶抑制剂，IC50 为 4 μM, 8 μM, 12 μM 和 240 μM 用于 cGMP 依赖性蛋白激酶 (PKG)、cAMP 依赖性蛋白激酶 (PKA) ，分别为蛋白激酶 C (PKC) 和 MLC 激酶。 C-1 也用作 ROCK 抑制剂。 | ||||
| GC11635 | TA 02 | 1784751-19-4 | >99.50% | |
An inducer of cardiomyocyte differentiation | ||||
| GC11857 | Pexmetinib (ARRY-614) | 945614-12-0 | >98.00% | |
A dual inhibitor of Tie2 and p38 MAPK | ||||
| GC11922 | SB 706504 | 911110-38-8 | - | |
p38 MAPK inhibitor | ||||
| GC12006 | GDC-0994 | 1453848-26-4 | >99.00% | |
A selective ERK1/2 inhibitor | ||||
| GC12089 | LY2584702 | 1082949-67-4 | >98.00% | |
A p70S6K inhibitor | ||||
| GC12124 | Selonsertib (GS-4997) | 1448428-04-3 | >98.50% | |
An ASK1 inhibitor | ||||
| GC12201 | HI TOPK 032 | 487020-03-1 | >99.00% | |
An inhibitor of TOPK, Chk1, and MEK1 kinases | ||||
| GC12220 | BIX 02189 | 1265916-41-3 | >99.50% | |
An inhibitor of MEK5 and ERK5 | ||||
| GC12297 | AT7867 | 857531-00-1 | >98.00% | |
A potent and orally bioavailable pan-Akt inhibitor | ||||
| GC12304 | OTS514 | 1338540-63-8 | >98.00% | |
A TOPK inhibitor | ||||
| GC12406 | RO5126766(CH5126766) | 946128-88-7 | >98.00% | |
A dual inhibitor of MEK1 and Raf kinases | ||||
| GC12486 | Dabrafenib Mesylate (GSK-2118436) | 1195768-06-9 | >99.50% | |
A Raf kinase inhibitor | ||||
| GC12532 | CHPG | 170846-74-9 | >98.00% | |
A potent and selective mGluR5 agonist | ||||